Role of RNA structure and protein factors in the control of HIV-1 splicing

Frontiers in Bioscience

Volumn 14, Issue 7, 2009, Pages 2714-2729

  Saliou, Jean Michel ^a   Bourgeois, Cyril F ^b,c,d,e   Mena, Lilia Ayadi Ben ^a   Ropers, Delphine ^a   Jacquenet, Sandrine ^a   Marchand, Virginie ^a   Stevenin, James ^b,c,d,e   Branlant, Christiane ^a  

^a Biopôle de l Université de Lorraine   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c INSERM   (France)

^d CNRS   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Alternative splicing; HIV 1; Hnrnp proteins; RNA structure; Splicing enhancer; Splicing silencer; SR proteins

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MAMMALIA;

VIRUS PROTEIN; VIRUS RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CHEMISTRY; CONFORMATION; EXON; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; PHYSIOLOGY; REGULATORY SEQUENCE;

ALTERNATIVE SPLICING; EXONS; HIV-1; NUCLEIC ACID CONFORMATION; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, VIRAL; VIRAL PROTEINS;

EID: 63849286646     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3408     Document Type: Article

References (96)

1. Johnson, J. M., J. Castle, P. Garrett-Engele, Z. Kan, P. M. Loerch, C. D. Armour, R. Santos, E. E. Schadt, R. Stoughton and D. D. Shoemaker: Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science, 302, 2141-4 (2003). (Pubitemid 38017950)
2. Wang, Z. and C. B. Burge: Splicing regulation: From a parts list of regulatory elements to an integrated splicing code. RNA (2008).
3. Matlin, A. J., F. Clark and C. W. Smith: Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol, 6, 386-98 (2005). (Pubitemid 40637856)
4. Maniatis, T. and R. Reed: An extensive network of coupling among gene expression machines. Nature, 416, 499-506 (2002). (Pubitemid 34288845)
5. Buratti, E., A. F. Muro, M. Giombi, D. Gherbassi, A. Iaconcig and F. E. Baralle: RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon. Mol Cell Biol, 24, 1387-400 (2004). (Pubitemid 38112198)
6. Karn, J.: Tackling Tat. J Mol Biol, 293, 235-54. (1999). (Pubitemid 29516167)
7. Peterlin, B. M. and D. H. Price: Controlling the elongation phase of transcription with P-TEFb. Mol Cell, 23, 297-305 (2006). (Pubitemid 44128850)
8. Purcell, D. F. and M. A. Martin: Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol., 67, 6365-78 (1993). (Pubitemid 23309100)
9. Benko, D. M., S. Schwartz, G. N. Pavlakis and B. K. Felber: A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. J Virol, 64, 2505-18 (1990). (Pubitemid 20171234)
10. Salemi, M., K. Strimmer, W. W. Hall, M. Duffy, E. Delaporte, S. Mboup, M. Peeters and A. M. Vandamme: Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution. FASEB J, 15, 276-8 (2001).
11. Lutzelberger, M., L. S. Reinert, A. T. Das, B. Berkhout and J. Kjems: A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability. J Biol Chem, 281, 18644-51 (2006). (Pubitemid 44035524)
12. Schwartz, S., B. K. Felber, D. M. Benko, E. M. Fenyo and G. N. Pavlakis: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol, 64, 2519-29 (1990). (Pubitemid 20171235)
13. Kestler, H. W., 3rd, D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel and R. C. Desrosiers: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell, 65, 651-62 (1991).
14. Hope, T. J.: The ins and outs of HIV Rev. Arch Biochem Biophys, 365, 186-91 (1999). (Pubitemid 29391625)
15. Popov, S., M. Rexach, G. Zybarth, N. Reiling, M. A. Lee, L. Ratner, C. M. Lane, M. S. Moore, G. Blobel and M. Bukrinsky: Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J, 17, 909-17 (1998). (Pubitemid 28077645)
16. Ohagen, A. and D. Gabuzda: Role of Vif in stability of the human immunodeficiency virus type 1 core. J Virol, 74, 11055-66 (2000). (Pubitemid 32223970)
17. O'Reilly, M. M., M. T. McNally and K. L. Beemon: Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology, 213, 373-85 (1995).
18. Damier, L.: Etude de la régulation de l'épissage du transcrit primaire du virus de l'immunodéficience humaine de type 1. Université de Nancy 1 (1997).
19. Kammler, S., C. Leurs, M. Freund, J. Krummheuer, K. Seidel, T. O. Tange, M. K. Lund, J. Kjems, A. Scheid and H. Schaal: The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steadystate level of an unstable env pre-mRNA. RNA, 7, 421-34 (2001). (Pubitemid 32385207)
20. Caputi, M., M. Freund, S. Kammler, C. Asang and H. Schaal: A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. J Virol, 78, 6517-26 (2004). (Pubitemid 38715950)
21. Bohne, J., H. Wodrich and H. G. Krausslich: Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end. Nucleic Acids Res, 33, 825-37 (2005). (Pubitemid 41435020)
22. Baudin, F., R. Marquet, C. Isel, J. L. Darlix, B. Ehresmann and C. Ehresmann: Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains. J Mol Biol, 229, 382-97 (1993). (Pubitemid 23080387)
23. Abbink, T. E., M. Ooms, P. C. Haasnoot and B. Berkhout: The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochemistry, 44, 9058-66 (2005). (Pubitemid 40943220)
24. Abbink, T. E. and B. Berkhout: RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor. J Virol, 82, 3090-8 (2008). (Pubitemid 351329197)
25. Madsen, J. M. and C. M. Stoltzfus: An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication. J Virol, 79, 10478-86 (2005). (Pubitemid 41102234)
26. Madsen, J. M. and C. M. Stoltzfus: A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication. Retrovirology, 3, 10 (2006).
27. Ashe, M. P., L. H. Pearson and N. J. Proudfoot: The HIV-1 5' LTR poly (A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site. EMBO J, 16, 5752-63 (1997). (Pubitemid 27399866)
28. Ashe, M. P., A. Furger and N. J. Proudfoot: Stem-loop 1 of the U1 snRNP plays a critical role in the suppression of HIV-1 polyadenylation. RNA, 6, 170-7 (2000). (Pubitemid 30091588)
29. Damgaard, C. K., S. Kahns, S. Lykke-Andersen, A. L. Nielsen, T. H. Jensen and J. Kjems: A 5' splice site enhances the recruitment of basal transcription initiation factors in vivo. Mol Cell, 29, 271-8 (2008). (Pubitemid 351172825)
30. Staffa, A. and A. Cochrane: The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site. J Virol, 68, 3071-9 (1994).
31. Si, Z., B. A. Amendt and C. M. Stoltzfus: Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res, 25, 861-7 (1997). (Pubitemid 27299844)
32. Jacquenet, S., D. Ropers, P. S. Bilodeau, L. Damier, A. Mougin, C. M. Stoltzfus and C. Branlant: Conserved stemloop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing. Nucleic Acids Res, 29, 464-78 (2001). (Pubitemid 32060933)
33. Damier, L., L. Domenjoud and C. Branlant: The D1-A2 and D2-A2 pairs of splice sites from human immunodeficiency virus type 1 are highly efficient in vitro, in spite of an unusual branch site. Biochem Biophys Res Commun, 237, 182-7 (1997). (Pubitemid 27390348)
34. Swanson, A. K. and C. M. Stoltzfus: Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs. J Biol Chem, 273, 34551-7 (1998).
35. Tange, T. O. and J. Kjems: SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain. J Mol Biol, 312, 649-62 (2001). (Pubitemid 33120935)
36. Dyhr-Mikkelsen, H. and J. Kjems: Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro. J Biol Chem, 270, 24060-6 (1995).
37. Kammler, S., M. Otte, I. Hauber, J. Kjems, J. Hauber and H. Schaal: The strength of the HIV-1 3' splice sites affects Rev function. Retrovirology, 3, 89 (2006).
38. Marchand, V., A. Mereau, S. Jacquenet, D. Thomas, A. Mougin, R. Gattoni, J. Stevenin and C. Branlant: A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. J Mol Biol, 323, 629-52 (2002). (Pubitemid 36160221)
39. Damgaard, C. K., T. O. Tange and J. Kjems: hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. RNA, 8, 1401-15 (2002). (Pubitemid 35332964)
40. Caputi, M., A. Mayeda, A. R. Krainer and A. M. Zahler: hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J, 18, 4060-7 (1999). (Pubitemid 29335858)
41. Bilodeau, P. S., J. K. Domsic, A. Mayeda, A. R. Krainer and C. M. Stoltzfus: RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J Virol, 75, 8487-97 (2001). (Pubitemid 32768953)
42. Jacquenet, S., A. Mereau, P. S. Bilodeau, L. Damier, C. M. Stoltzfus and C. Branlant: A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J Biol Chem, 276, 40464-75 (2001).
43. Tange, T. O., C. K. Damgaard, S. Guth, J. Valcarcel and J. Kjems: The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J, 20, 5748-58 (2001). (Pubitemid 33014352)
44. Zhu, J., A. Mayeda and A. R. Krainer: Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol Cell, 8, 1351-61 (2001). (Pubitemid 34086947)
45. Asai, K., C. Platt and A. Cochrane: Control of HIV-1 env RNA splicing and transport: investigating the role of hnRNP A1 in exon splicing silencer (ESS3a) function. Virology, 314, 229-42 (2003). (Pubitemid 37153313)
46. Zahler, A. M., C. K. Damgaard, J. Kjems and M. Caputi: SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV- 1 tat exon 2 splicing. J Biol Chem, 279, 10077-84 (2004). (Pubitemid 38372611)
47. Hallay, H., N. Locker, L. Ayadi, D. Ropers, E. Guittet and C. Branlant: Biochemical and NMR study on the competition between proteins SC35, SRp40 and hnRNP A1 at the HIV-1 Tat exon 2 splicing site. J Biol Chem (2006).
48. Ropers, D., L. Ayadi, R. Gattoni, S. Jacquenet, L. Damier, C. Branlant and J. Stevenin: Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. J Biol Chem, 279, 29963-73 (2004). (Pubitemid 38937916)
49. Stoltzfus, C. M. and J. M. Madsen: Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Curr HIV Res, 4, 43-55 (2006).
50. Domsic, J. K., Y. Wang, A. Mayeda, A. R. Krainer and C. M. Stoltzfus: Human immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polypyrimidine tracts. Mol Cell Biol, 23, 8762-72 (2003). (Pubitemid 37433377)
51. Jacquenet, S., D. Decimo, D. Muriaux and J. L. Darlix: Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology, 2, 33 (2005).
52. Bakkour, N., Y. L. Lin, S. Maire, L. Ayadi, F. Mahuteau-Betzer, C. H. Nguyen, C. Mettling, P. Portales, D. Grierson, B. Chabot, P. Jeanteur, C. Branlant, P. Corbeau and J. Tazi: Small-molecule inhibition of HIV premRNA splicing as a novel antiretroviral therapy to overcome drug resistance. PLoS Pathog, 3, 1530-9 (2007). (Pubitemid 350085616)
53. Bourgeois, C. F., F. Lejeune and J. Stevenin: Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA. Prog Nucleic Acid Res Mol Biol, 78, 37-88 (2004). (Pubitemid 39753917)
54. Zheng, Z. M.: Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression. J Biomed Sci, 11, 278-94 (2004).
55. Tacke, R. and J. L. Manley: The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J., 14, 3540-51 (1995).
56. Smith, P. J., C. Zhang, J. Wang, S. L. Chew, M. Q. Zhang and A. R. Krainer: An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet, 15, 2490-508 (2006). (Pubitemid 44288702)
57. Amendt, B. A., Z. H. Si and C. M. Stoltzfus: Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol, 15, 4606-15 (1995).
58. Dreyfuss, G., M. J. Matunis, S. Pinol-Roma and C. G. Burd: hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem., 62, 289-321 (1993). (Pubitemid 23237873)
59. Cartegni, L., M. Maconi, E. Morandi, F. Cobianchi, S. Riva and G. Biamonti: hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J Mol Biol, 259, 337-48 (1996). (Pubitemid 26179016)
60. Casas-Finet, J. R., J. D. Smith, Jr., A. Kumar, J. G. Kim, S. H. Wilson and R. L. Karpel: Mammalian heterogeneous ribonucleoprotein A1 and its constituent domains. Nucleic acid interaction, structural stability and self-association. J Mol Biol, 229, 873-89 (1993). (Pubitemid 23091809)
61. Sanford, J. R., J. Ellis and J. F. Caceres: Multiple roles of arginine/serine-rich splicing factors in RNA processing. Biochem Soc Trans, 33, 443-6 (2005). (Pubitemid 40873861)
62. Huang, Y. and J. A. Steitz: SRprises along a messenger's journey. Mol Cell, 17, 613-5 (2005). (Pubitemid 40320911)
63. Amendt, B. A., D. Hesslein, L. J. Chang and C. M. Stoltzfus: Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol Cell Biol, 14, 3960-70 (1994). (Pubitemid 24160802)
64. Mayeda, A., G. R. Screaton, S. D. Chandler, X. D. Fu and A. R. Krainer: Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mol. Cell. Biol., 19, 1853-63 (1999). (Pubitemid 29098243)
65. Pongoski, J., K. Asai and A. Cochrane: Positive and negative modulation of human immunodeficiency virus type 1 Rev function by cis and trans regulators of viral RNA splicing. J Virol, 76, 5108-20 (2002). (Pubitemid 34441715)
66. Woolaway, K., K. Asai, A. Emili and A. Cochrane: hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression. Retrovirology, 4, 28 (2007).
67. Exline, C. M., Z. Feng and C. M. Stoltzfus: Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression. J Virol, 82, 3921-31 (2008). (Pubitemid 351521229)
68. Eperon, I. C., O. V. Makarova, A. Mayeda, S. H. Munroe, J. F. Caceres, D. G. Hayward and A. R. Krainer: Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol Cell Biol, 20, 8303-18 (2000).
69. Dowling, D., S. Nasr-Esfahani, C. H. Tan, K. O'Brien, J. L. Howard, D. A. Jans, D. F. Purcell, C. M. Stoltzfus and S. Sonza: HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages. Retrovirology, 5, 18 (2008).
70. Maldarelli, F., C. Xiang, G. Chamoun and S. L. Zeichner: The expression of the essential nuclear splicing factor SC35 is altered by human immunodeficiency virus infection. Virus Res, 53, 39-51. (1998). (Pubitemid 28127843)
71. Ryo, A., Y. Suzuki, M. Arai, N. Kondoh, T. Wakatsuki, A. Hada, M. Shuda, K. Tanaka, C. Sato, M. Yamamoto and N. Yamamoto: Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells. AIDS Res Hum Retroviruses, 16, 995-1005 (2000). (Pubitemid 30436498)
72. Fukuhara, T., T. Hosoya, S. Shimizu, K. Sumi, T. Oshiro, Y. Yoshinaka, M. Suzuki, N. Yamamoto, L. A. Herzenberg and M. Hagiwara: Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc Natl Acad Sci U S A, 103, 11329-33 (2006). (Pubitemid 44156517)
73. Kanopka, A., O. Muhlemann, S. Petersen-Mahrt, C. Estmer, C. Ohrmalm and G. Akusjarvi: Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature, 393, 185-7 (1998). (Pubitemid 28242261)
74. Sciabica, K. S., Q. J. Dai and R. M. Sandri-Goldin: ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J, 22, 1608-19 (2003). (Pubitemid 36417409)
75. Schaub, M. C., S. R. Lopez and M. Caputi: Members of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexes. J Biol Chem, 282, 13617-26 (2007). (Pubitemid 47100498)
76. Martinez-Contreras, R., J. F. Fisette, F. U. Nasim, R. Madden, M. Cordeau and B. Chabot: Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate premRNA splicing. PLoS Biol, 4, e21 (2006).
77. Caputi, M. and A. M. Zahler: SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. EMBO J, 21, 845-55 (2002). (Pubitemid 34174064)
78. Hashizume, C., M. Kuramitsu, X. Zhang, T. Kurosawa, M. Kamata and Y. Aida: Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition. Microbes Infect, 9, 490-7 (2007). (Pubitemid 46436550)
79. Kuramitsu, M., C. Hashizume, N. Yamamoto, A. Azuma, M. Kamata, Y. Tanaka and Y. Aida: A novel role for Vpr of human immunodeficiency virus type 1 as a regulator of the splicing of cellular pre-mRNA. Microbes Infect, 7, 1150-60 (2005). (Pubitemid 41316688)
80. Bohne, J., A. Schambach and D. Zychlinski: New way of regulating alternative splicing in retroviruses: the promoter makes a difference. J Virol, 81, 3652-6 (2007). (Pubitemid 46456676)
81. Nogues, G., S. Kadener, P. Cramer, D. Bentley and A. R. Kornblihtt: Transcriptional activators differ in their abilities to control alternative splicing. J Biol Chem, 277, 43110-4 (2002). (Pubitemid 35285694)
82. Fong, Y. W. and Q. Zhou: Stimulatory effect of splicing factors on transcriptional elongation. Nature, 414, 929-33 (2001). (Pubitemid 34024746)
83. Bres, V., N. Gomes, L. Pickle and K. A. Jones: A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat. Genes Dev, 19, 1211-26 (2005). (Pubitemid 40696187)
84. Bieniasz, P. D. and B. R. Cullen: Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol, 74, 9868-77 (2000).
85. Garber, M. E., P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman and K. A. Jones: The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev, 12, 3512-27 (1998). (Pubitemid 28553243)
86. Zheng, Y. H., H. F. Yu and B. M. Peterlin: Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat Cell Biol, 5, 611-8 (2003). (Pubitemid 36818082)
87. Petersen-Mahrt, S. K., C. Estmer, C. Ohrmalm, D. A. Matthews, W. C. Russell and G. Akusjarvi: The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J, 18, 1014-24 (1999). (Pubitemid 29082280)
88. Ohrmalm, C. and G. Akusjarvi: Cellular splicing and transcription regulatory protein p32 represses adenovirus major late transcription and causes hyperphosphorylation of RNA polymerase II. J Virol, 80, 5010-20 (2006).
89. Berro, R., K. Kehn, C. de la Fuente, A. Pumfery, R. Adair, J. Wade, A. M. Colberg-Poley, J. Hiscott and F. Kashanchi: Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. J Virol, 80, 3189-204 (2006).
90. Kaehlcke, K., A. Dorr, C. Hetzer-Egger, V. Kiermer, P. Henklein, M. Schnoelzer, E. Loret, P. A. Cole, E. Verdin and M. Ott: Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol Cell, 12, 167-76 (2003). (Pubitemid 36945045)
91. Ott, M., A. Dorr, C. Hetzer-Egger, K. Kaehlcke, M. Schnolzer, P. Henklein, P. Cole, M. M. Zhou and E. Verdin: Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation. Novartis Found Symp, 259, 182-93; discussion 193-6, 223-5 (2004).
92. Nogues, G., S. Kadener, P. Cramer, M. de la Mata, J. P. Fededa, M. Blaustein, A. Srebrow and A. R. Kornblihtt: Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better. IUBMB Life, 55, 235-41 (2003). (Pubitemid 36842254)
93. Soret, J., N. Bakkour, S. Maire, S. Durand, L. Zekri, M. Gabut, W. Fic, G. Divita, C. Rivalle, D. Dauzonne, C. H. Nguyen, P. Jeanteur and J. Tazi: Selective modification of alternative splicing by indole derivatives that target serinearginine-rich protein splicing factors. Proc Natl Acad Sci U S A, 102, 8764-9 (2005). (Pubitemid 40862809)
94. Asparuhova, M. B., G. Marti, S. Liu, F. Serhan, D. Trono and D. Schumperli: Inhibition of HIV-1 multiplication by a modified U7 snRNA inducing Tat and Rev exon skipping. J Gene Med, 9, 323-34 (2007). (Pubitemid 46796578)
95. Gottlinger, H. G., T. Dorfman, E. A. Cohen and W. A. Haseltine: The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates. Virology, 189, 618-28 (1992).
96. Staffa, A. and A. Cochrane: Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol Cell Biol, 15, 4597-605 (1995).